Rev Genomics
YC S17San Francisco, US · Founded 2016 · California corporation · 8 employees · Hiring · 2 known investors
Find your way into Rev Genomics
452 people in our graph share verified history with the Rev Genomics team — schools, employers, funds. One of them is your warm intro.
Viswa Sankaranarayananunlockedknows Bertrand Vick · together at The University of Texas at Austin (overlapped)
knows the team · via The University of Texas at Austin
×10knows the team · via University of California, Berkeley
Rev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks. The company creates novel plant phenotypes and provides molecular fingerprinting and breeding technology primarily for specialty crops in California.
Also known as Inc.
Founders & leadership· Y Combinator alumni (S17)
Rev Genomics was founded in 2016 by Bertrand Vick and Robert John Markelz.
BV
Bertrand VickinCo-founder · CEOBertrand Vick is the founder and CEO of Rev Genomics, which develops high-value crop cultivars for breeders and seed banks using genomic selection and molecular analysis. He previously founded and served as Chief Scientific Officer of Aurora Algae Inc., bringing expertise in molecular genetics, strain development, and biotechnology operations.
RJ
Robert John MarkelzCo-founder
GE
Gloria E WebsterNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2019
▶$1.5MraisedMay 2019 · 36 investors · BiotechnologyRule 506(c)
▶$1.5MraisedMay 2019 · 36 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Bertrand VickExecutive Officer, Director, Promoter
- Robert John MarkelzExecutive Officer, Director, Promoter
- Gloria E WebsterDirector, Promoter
- James Edward LongPromoter
- Offering amount
- $2M
- Amount sold
- $1.5M
- Minimum investment
- $5K
- Proceeds to insiders
- $50K
- First sale
- Apr 2019
- Incorporated
- Corporation, California, 2016
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlap
Polaris Genomics10 shared keywordsPolaris Genomics is a Veteran-owned biotech startup mapping molecular biomarkers to develop objective, biologically-based diagnostics and novel therapeutics for mental health and neuropsychiatric conditions such as PTSD. It combines genomics and AI to advance precision mental health care.
Verinomics8 shared keywordsVerinomics develops crop improvement technology by combining genomics, computational biology, and a transgene-free gene editing platform, with an AI-driven population genomics tool to identify high-value trait genes. It serves breeding programs, agricultural businesses, and research institutions focused on specialty and vegetatively propagated crops such as leafy greens.
Phase Genomics7 shared keywordsPhase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity. It serves academic and research institutions and biopharmaceutical firms across life sciences, medicine, and agriculture.
Revvity6 shared keywordsRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
Orbit Genomics6 shared keywordsOrbit Genomics is a precision healthcare company built on OrbiSeq, an AI-enabled genomics platform that analyzes short tandem repeats (STRs) alongside single nucleotide polymorphisms to detect disease biology. Its lead product is a blood test for diagnosing early-stage lung cancer in patients with indeterminate pulmonary nodules, with a pipeline extending across other therapeutic areas.
10x Genomics 1-color6 shared keywords10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
Companies competing with Rev Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Rev Genomics do?
- Rev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks. The company creates novel plant phenotypes and provides molecular fingerprinting and breeding technology primarily for specialty crops in California.
- Who founded Rev Genomics?
- Rev Genomics was founded by Bertrand Vick, Robert John Markelz in 2016.
- Who are Rev Genomics's investors?
- Rev Genomics's investors include Y Combinator, Merida Capital Holdings.
- How much funding has Rev Genomics raised?
- Rev Genomics has disclosed $1.5M raised across 1 round.
- Where is Rev Genomics headquartered?
- Rev Genomics is headquartered in San Francisco, US.